Literature DB >> 28161812

Tumor Grade versus Expression of Invasion-Related Molecules in Astrocytoma.

József Virga1, László Bognár1, Tibor Hortobágyi2, Gábor Zahuczky3, Éva Csősz4, Gergő Kalló4, Judit Tóth5, Gábor Hutóczki1, Judit Reményi-Puskár1, László Steiner3, Almos Klekner6.   

Abstract

Peritumoral infiltration is characteristic of astrocytomas even in low-grade tumors. Tumor cells migrate to neighbouring tissue and cause recurrence. The extracellular matrix (ECM) plays a role in tumor invasion; expression levels of its components' have been linked to tumor invasion. This study determines the mRNA and protein expression of 20 invasion-related ECM components by examining non-tumor brain; grade I-II-III astrocytoma and glioblastoma samples. Expression levels were measured by QRT-PCR and mass-spectroscopy. The connection between the expression pattern and tumor grade is statistically analyzed. During the analysis of data, key molecules (brevican, cadherin-12, fibronectin and integrin-β1) correlating the most with tumor grade were selected. While the mRNA level of brevican, ErbB2, fibronectin, integrin-β1 and versican discriminates low-grade from high-grade gliomas, of proteins RHAMM, integrin-α1 and MMP2 seems important. The expression pattern was found to be distinctive for tumor grade, as statistical classifiers are capable of identifying an unknown sample's grade using them. Furthermore, normal brain and glioma expression patterns, along with low-grade astrocytoma and glioblastoma samples, differ the most. Determining the invasion-related molecules' expression profile provides extra information regarding the tumor's clinical behavior. Additionally, identifying molecules playing a key role in glioma invasion could uncover potential therapeutic targets in the future.

Entities:  

Keywords:  Expression; Extracellular matrix; Gliomas; Invasion; Tumor grade

Mesh:

Substances:

Year:  2017        PMID: 28161812     DOI: 10.1007/s12253-017-0194-6

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  43 in total

Review 1.  Chondroitin sulfate proteoglycans in tumor progression.

Authors:  Yanusz Wegrowski; François-Xavier Maquart
Journal:  Adv Pharmacol       Date:  2006

Review 2.  Biological mechanisms of glioma invasion and potential therapeutic targets.

Authors:  B B Tysnes; R Mahesparan
Journal:  J Neurooncol       Date:  2001-06       Impact factor: 4.130

Review 3.  Genetics of adult glioma.

Authors:  McKinsey L Goodenberger; Robert B Jenkins
Journal:  Cancer Genet       Date:  2012-12-11

4.  Overexpression of alpha4 chain-containing laminins in human glial tumors identified by gene microarray analysis.

Authors:  J Y Ljubimova; A J Lakhter; A Loksh; W H Yong; M S Riedinger; J H Miner; L M Sorokin; A V Ljubimov; K L Black
Journal:  Cancer Res       Date:  2001-07-15       Impact factor: 12.701

5.  Clinical impact and functional aspects of tenascin-C expression during glioma progression.

Authors:  Christel Herold-Mende; Margareta M Mueller; Mario M Bonsanto; Horst Peter Schmitt; Stefan Kunze; Hans-Herbert Steiner
Journal:  Int J Cancer       Date:  2002-03-20       Impact factor: 7.396

6.  Downregulation of laminin alpha4 chain expression inhibits glioma invasion in vitro and in vivo.

Authors:  Shigeyuki Nagato; Kou Nakagawa; Hironobu Harada; Shohei Kohno; Hironobu Fujiwara; Kiyotoshi Sekiguchi; Shiro Ohue; Shinji Iwata; Takanori Ohnishi
Journal:  Int J Cancer       Date:  2005-10-20       Impact factor: 7.396

7.  Effect of ERBB2 expression on invasiveness of glioma TJ905 cells.

Authors:  Gao-Feng Xu; Wan-Fu Xie
Journal:  Asian Pac J Trop Med       Date:  2013-12       Impact factor: 1.226

8.  Tenascin-C regulates angiogenesis in tumor through the regulation of vascular endothelial growth factor expression.

Authors:  Keiichiro Tanaka; Noriko Hiraiwa; Hisashi Hashimoto; Yoji Yamazaki; Moriaki Kusakabe
Journal:  Int J Cancer       Date:  2004-01-01       Impact factor: 7.396

9.  Syndecan-1 antigen, a promising new target for triple-negative breast cancer immuno-PET and radioimmunotherapy. A preclinical study on MDA-MB-468 xenograft tumors.

Authors:  Caroline Rousseau; Anne Lise Ruellan; Karine Bernardeau; Françoise Kraeber-Bodéré; Sebastien Gouard; Delphine Loussouarn; Catherine Saï-Maurel; Alain Faivre-Chauvet; John Wijdenes; Jacques Barbet; Joëlle Gaschet; Michel Chérel; François Davodeau
Journal:  EJNMMI Res       Date:  2011-09-01       Impact factor: 3.138

10.  Cadherin-12 contributes to tumorigenicity in colorectal cancer by promoting migration, invasion, adhersion and angiogenesis.

Authors:  Jingkun Zhao; Pu Li; Hao Feng; Puxiongzhi Wang; Yaping Zong; Junjun Ma; Zhuo Zhang; Xuehua Chen; Minhua Zheng; Zhenggang Zhu; Aiguo Lu
Journal:  J Transl Med       Date:  2013-11-15       Impact factor: 5.531

View more
  2 in total

1.  Improved Antiglioblastoma Activity and BBB Permeability by Conjugation of Paclitaxel to a Cell-Penetrative MMP-2-Cleavable Peptide.

Authors:  Dan Hua; Lida Tang; Weiting Wang; Shengan Tang; Lin Yu; Xuexia Zhou; Qian Wang; Cuiyun Sun; Cuijuan Shi; Wenjun Luo; Zhendong Jiang; Huining Li; Shizhu Yu
Journal:  Adv Sci (Weinh)       Date:  2020-12-21       Impact factor: 16.806

Review 2.  The scrambled story between hyaluronan and glioblastoma.

Authors:  Matías Arturo Pibuel; Daniela Poodts; Mariángeles Díaz; Silvia Elvira Hajos; Silvina Laura Lompardía
Journal:  J Biol Chem       Date:  2021-03-17       Impact factor: 5.157

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.